Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England

Tools

Kuo, Chang-Fu, Grainge, Matthew J., Mallen, Christian, Zhang, Weiya and Doherty, Michael (2014) Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England. Journal of the American Medical Association, 312 (24). pp. 2684-2686. ISSN 0098-7484

Full text not available from this repository.

Official URL: http://jama.jamanetwork.com/article.aspx?articleid=2084879

Abstract

Gout is caused by urate crystal deposition secondary to persistent hyperuricemia. Current guidelines recommend urate-lowering treatment to prevent crystal deposition and encourage crystal dissolution for patients with more severe gout or concomitant conditions.1,2 However, after the first diagnosis, it remains unclear when such treatment is appropriate. We investigated the timing of eligibility for and prescription of urate-lowering treatment following first gout diagnosis and factors associated with prescription.

Item Type:	Article
RIS ID:	https://nottingham-repository.worktribe.com/output/740521
Schools/Departments:	University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Medicine > Division of Epidemiology and Public Health University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Medicine > Division of Rheumatology, Orthopaedics and Dermatology
Identification Number:	https://doi.org/10.1001/jama.2014.14484
Depositing User:	Claringburn, Tara
Date Deposited:	18 Aug 2016 15:14
Last Modified:	04 May 2020 16:58
URI:	https://eprints.nottingham.ac.uk/id/eprint/35899

Actions (Archive Staff Only)

Edit View

LoginAdmin